Iqbal J. Hussain

All filings by Iqbal J. Hussain on record concern Centessa Pharmaceuticals plc, in the capacity of senior executive. The record holds 32 filings, for trades running from 2 June 2021 to 24 June 2026.

In open-market terms, that means 1 purchase worth €49k on one side and 2 sales worth €37k on the other. Taken together, the purchases exceed the sales by €13k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 14 share grants and 13 option exercises. Since January 2026: no purchases and 1 sale on the market.

Most recently, on 24 June 2026, the filings show a transaction in Centessa Pharmaceuticals plc. The last insider purchase was made public on 4 June 2021, 1,962 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.